Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Alphatec Holdings's share price for the quarter that ended in Mar. 2026 was €9.374. Alphatec Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 152.0 Mil. Therefore, Alphatec Holdings's market cap for the quarter that ended in Mar. 2026 was €1,424.7 Mil.
Alphatec Holdings's quarterly market cap
increased
from Sep. 2025 (€1,808.8 Mil) to Dec. 2025 (€2,598.6 Mil) but then
declined
from Dec. 2025 (€2,598.6 Mil) to Mar. 2026 (€1,424.7 Mil).
Alphatec Holdings's annual market cap
declined
from Dec. 2023 (€1,907.7 Mil) to Dec. 2024 (€1,239.5 Mil) but then
increased
from Dec. 2024 (€1,239.5 Mil) to Dec. 2025 (€2,598.6 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Alphatec Holdings's Enterprise Value for Today is €1,611.3 Mil.
Alphatec Holdings (FRA:L1Z1) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Alphatec Holdings Market Cap Related Terms
Alphatec Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for Alphatec Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:L1Z1 vs IART, AHCO, INSP: Market Cap Comparison
For the Medical Devices subindustry, Alphatec Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alphatec Holdings Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Alphatec Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Alphatec Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Alphatec Holdings's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alphatec Holdings (FRA:L1Z1) has a Market Cap of €1,204.6 Mil as of Jul. 06, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Alphatec Holdings and its competitors. According to the industry distribution chart, Alphatec Holdings ranks #143 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 16.5%.
Is Alphatec Holdings' Market Cap too high?
Alphatec Holdings' current Market Cap is €1,204.6 Mil. Based on the distribution chart, Alphatec Holdings ranks #143 out of 868 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Alphatec Holdings has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Alphatec Holdings' Market Cap compare to IART and AHCO?
According to the Medical Devices & Instruments industry distribution chart, Alphatec Holdings ranks #143 out of 868 companies for Market Cap. This places Alphatec Holdings in the top 17% of its industry — outperforming the majority of peers. The industry median Market Cap is 120.17. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 120.17, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Alphatec Holdings and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 120.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alphatec Holdings's current Market Cap is €1,204.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alphatec Holdings stock overvalued right now?
Alphatec Holdings (FRA:L1Z1) has a current Market Cap of €1,204.6 Mil. The stock's GF Value™ is €13.06, compared to a current price of €7.60 — trading 41.8% below its estimated fair value. The current Market Cap is €1,204.6 Mil. Alphatec Holdings' overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Alphatec Holdings (FRA:L1Z1), the current Market Cap is €1,204.6 Mil as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alphatec Holdings (FRA:L1Z1) Overvalued in 2026?
Based on GuruFocus' analysis, Alphatec Holdings stock appears to be undervalued.
The current stock price of €7.60 is trading 41.8% below its estimated GF Value™ of €13.06.
Key valuation signals for FRA:L1Z1:
Market Cap: €1,204.6 Mil
GF Value™: €13.06 vs. price of €7.60 (41.8% below fair value)
No single metric tells the full story. See the FRA:L1Z1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
62GF Score
Get the complete analysis for FRA:L1Z1
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L1Z1 has been successfully added to your 
